Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis | Immunology
Chan P et al. | qP contributors: Prohn M, Huisman J, Matzuka B | 2020| Journal| Pharmaceutical Research Link
A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) With Poor Prognosis Features | Oncology
Sarkozy C et al. | qP contributors: Suttle B | 2020| Journal| Clinical Cancer Research Link
SAGE-217: A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies | CNS
Hoffmann E et al. | qP contributors: Wald J | 2020| Journal| Clinical Pharmacokinetics Link